NO304314B1 - Cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler - Google Patents

Cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler

Info

Publication number
NO304314B1
NO304314B1 NO951820A NO951820A NO304314B1 NO 304314 B1 NO304314 B1 NO 304314B1 NO 951820 A NO951820 A NO 951820A NO 951820 A NO951820 A NO 951820A NO 304314 B1 NO304314 B1 NO 304314B1
Authority
NO
Norway
Prior art keywords
drugs
compounds
manufacture
cyclohexane derivatives
cyclohexane
Prior art date
Application number
NO951820A
Other languages
English (en)
Norwegian (no)
Other versions
NO951820L (no
NO951820D0 (no
Inventor
Horst Hemmerle
Gerrit Schubert
Hans-J Rg Burger
Andreas Herling
Suad Efendic
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO951820D0 publication Critical patent/NO951820D0/no
Publication of NO951820L publication Critical patent/NO951820L/no
Publication of NO304314B1 publication Critical patent/NO304314B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO951820A 1994-05-10 1995-05-09 Cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler NO304314B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4416433A DE4416433A1 (de) 1994-05-10 1994-05-10 Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten

Publications (3)

Publication Number Publication Date
NO951820D0 NO951820D0 (no) 1995-05-09
NO951820L NO951820L (no) 1995-11-13
NO304314B1 true NO304314B1 (no) 1998-11-30

Family

ID=6517746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951820A NO304314B1 (no) 1994-05-10 1995-05-09 Cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler

Country Status (23)

Country Link
US (1) US5739147A (fr)
EP (1) EP0682024B1 (fr)
JP (1) JP3790564B2 (fr)
KR (1) KR100355690B1 (fr)
CN (1) CN1043643C (fr)
AT (1) ATE187454T1 (fr)
AU (1) AU683148B2 (fr)
CA (1) CA2149007C (fr)
CZ (1) CZ288443B6 (fr)
DE (2) DE4416433A1 (fr)
DK (1) DK0682024T3 (fr)
ES (1) ES2141276T3 (fr)
FI (1) FI110097B (fr)
GR (1) GR3032519T3 (fr)
HK (1) HK1011989A1 (fr)
HU (1) HU220865B1 (fr)
NO (1) NO304314B1 (fr)
NZ (1) NZ272082A (fr)
PL (1) PL180074B1 (fr)
RU (1) RU2140416C1 (fr)
TW (1) TW421648B (fr)
UA (1) UA41340C2 (fr)
ZA (1) ZA953726B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
DK1741447T3 (da) 2000-01-21 2013-12-09 Novartis Ag Kombinationer omfattende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler
AU2002254940A1 (en) * 2001-03-12 2002-09-24 Novartis Pharma Gmbh Combination of nateglinide or repaglinide with at least one further antidiabetic compound
AU2006290908C1 (en) 2005-09-14 2014-04-03 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetes
WO2011041293A1 (fr) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Dérivés pyrazolo [1, 5—a] pyrimidines comme inhibiteurs de kinase 1 régulatrice de signal d'apoptose
JP5711270B2 (ja) 2010-02-03 2015-04-30 武田薬品工業株式会社 アポトーシスシグナル調節キナーゼ１阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243016A (ja) * 1984-05-17 1985-12-03 Tsumura Juntendo Inc 抗インフルエンザウイルス剤
TW255880B (fr) * 1992-09-09 1995-09-01 Hoechst Ag
TW399041B (en) * 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases
DE4408082A1 (de) * 1994-03-10 1995-09-14 Hoechst Ag Substituierte Propan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE4413402A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Herstellung von Zwischenprodukten für die Synthese von Glucose-6-Phosphatase-Inhibitoren sowie neue Zwischenprodukte

Also Published As

Publication number Publication date
CA2149007C (fr) 2005-07-26
AU1792395A (en) 1995-11-16
CZ288443B6 (en) 2001-06-13
NZ272082A (en) 1996-09-25
KR100355690B1 (ko) 2002-12-26
NO951820L (no) 1995-11-13
AU683148B2 (en) 1997-10-30
PL180074B1 (pl) 2000-12-29
CA2149007A1 (fr) 1995-11-11
FI952203A (fi) 1995-11-11
DE4416433A1 (de) 1995-11-16
DK0682024T3 (da) 2000-05-22
UA41340C2 (uk) 2001-09-17
RU2140416C1 (ru) 1999-10-27
RU95107147A (ru) 1997-03-20
EP0682024B1 (fr) 1999-12-08
NO951820D0 (no) 1995-05-09
JP3790564B2 (ja) 2006-06-28
ZA953726B (en) 1996-01-11
CN1043643C (zh) 1999-06-16
US5739147A (en) 1998-04-14
EP0682024A1 (fr) 1995-11-15
FI110097B (fi) 2002-11-29
PL308521A1 (en) 1995-11-13
ES2141276T3 (es) 2000-03-16
HUT71797A (en) 1996-02-28
DE59507361D1 (de) 2000-01-13
HU220865B1 (en) 2002-06-29
KR950032191A (ko) 1995-12-20
FI952203A0 (fi) 1995-05-08
HK1011989A1 (en) 1999-07-23
TW421648B (en) 2001-02-11
JPH07330767A (ja) 1995-12-19
GR3032519T3 (en) 2000-05-31
ATE187454T1 (de) 1999-12-15
CN1118782A (zh) 1996-03-20
CZ119595A3 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DE69531476D1 (de) Serotonergische Modulatoren
FI971227A0 (fi) Pyramidinyylipyratsolijohdannaisia
DK0947504T3 (da) 16-en-vitamin D-derivater
NO304314B1 (no) Cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler
FI834730A0 (fi) 1-karboxialkanoylperhydro-indol-2-karboxylsyror och deras derivat
ATE192141T1 (de) Aromatische hydroxamsäure-verbindungen, ihre herstellung und verwendung
NO972943D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
FI872997A0 (fi) Amidderivat.
ES2098517T3 (es) Derivados de 1,2,4-tiadiazino(3,4-b)benzotiazol, su preparacion y los medicamentos que los contienen.
NO972942L (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
ATE17490T1 (de) Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DK0826663T3 (da) Alkynylaminosyrederivater og deres anvendelse som farmaceutiske forbindelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees